Related Experiment Videos
[The low-profile Liotta valve. Mid-term results]
A Pavie1, I Gandjbakhch, F Baud
1Service de Chirurgie cardio-vasculaire, hôpital de La Pitié, Paris.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|August 1, 1987
Summary
The Liotta xenograft heart valve demonstrated favorable mid-term outcomes in 257 patients, with a 3-year survival rate of 92.2% and a low complication rate. Functional improvement was observed in most patients receiving aortic and mitral valve replacements.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Medical Device Evaluation